CIK 0001873093 · Non-accelerated filer<br>Emerging growth company
CytoMed Therapeutics Ltd
Sign in to watch- Ticker
- GDTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Singapore
- Entity type
- other
- Phone
- 603824911
- Business address
- #08-22 ONE COMMONWEALTH, 1 COMMONWEALTH LANE, Singapore, 149544
- Former names
- CytoMed Therapeutics Pte. Ltd.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 144 Insider Sale of Securities
- 4/A Open-market buy Director bought 200,000 shares at $1.50 ($300,000)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 200,000 shares at $1.50 ($300,000)
- 6-K Event Report of Foreign Issuer
- 4 Open-market buy Director bought 112,000 shares at $1.15 ($128,778)
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 144 Insider Sale of Securities
Page 1 of 7 · 132 filings